Safety and Efficacy of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy

PHASE2CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

June 16, 2017

Conditions
Ovarian Cancer
Interventions
DRUG

Quisinostat

DRUG

Paclitaxel

DRUG

Carboplatin

Trial Locations (6)

115478

"Federal State budget Scientific Agency Russian Oncological Research Center n.a. N.N. Blokhin", Moscow

191014

"State Budget Agency of Healthcare Leningradsky Regional Oncologic Dispensary", Saint Petersburg

197758

"State Budget Healthcare Agency St-Petersburg clinical scientific-practical center of specialized types of medical care (oncology)", Saint Petersburg

249036

"Medical Radiological Scientific Center n.a. A.F. Tsyb - branch of Federal State Budget Agency Public Medical Scientific Radiology Center of Ministry of Health of Russian Federation", Obninsk

357502

State Budget Agency of Stavropol Territory Healthcare Pyatigorsk Oncologic Dispensary, Pyatigorsk

Unknown

"St-Petersburg State Budget Agency of Healthcare Municipal Clinical Oncological Dispensary", Saint Petersburg

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Janssen Pharmaceutica N.V., Belgium

INDUSTRY

lead

NewVac LLC

INDUSTRY